ERIC I RICHMAN

CIK 1313876 · CHIEF EXECUTIVE OFFICER · last filed 2025-06-25

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$852.8K

Companies

4

Total Filings

55

Lifetime Open-Market Net

-$414.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GANX Director 292,458 $1.68 $491.3K $102.8K 9 2025-06-25
NeuBase Therapeutics, Inc. (NBSE) Delisted Director 71,707 $0.38 $27.1K $96.4K 7 2022-09-12
ADMA Director 44,030 $8.21 $361.5K $106.3K 11 2020-03-03
Altimmune, Inc. (PIP) Delisted Director 454,895 -$719.7K 24 2016-11-23

Recent Filings · Page 4 of 6

55 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-08-04 Altimmune, Inc. (PIP) Delisted Grant (A) $0 EDGAR
2015-03-17 ADMA Buy (P) +3,500 $27.6K EDGAR
2015-02-03 ADMA Grant (A) $0 EDGAR
2014-12-15 Altimmune, Inc. (PIP) Delisted Grant (A) $0 EDGAR
2014-01-31 Altimmune, Inc. (PIP) Delisted Grant (A) $0 EDGAR
2012-12-14 Altimmune, Inc. (PIP) Delisted Grant (A) $0 EDGAR
2012-04-06 Grant (A) $0
2012-03-08 Altimmune, Inc. (PIP) Delisted Tax (F) −22,500 $0 EDGAR
2012-02-15 Grant (A) $0
2011-12-13 Altimmune, Inc. (PIP) Delisted Grant (A) +75,000 $0 EDGAR
Showing 3140 of 55
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.